Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss Journal Article


Authors: Fu, W.; Chen, M.; Wang, K.; Chen, Y.; Cui, Y.; Xie, Y.; Lei, Z. N.; Hu, W.; Sun, G.; Huang, G.; He, C.; Fretz, J.; Hettinghouse, A.; Liu, R.; Cai, X.; Zhang, M.; Chen, Y.; Jiang, N.; He, M.; Wiznia, D. H.; Xu, H.; Chen, Z. S.; Chen, L.; Tang, K.; Zhou, H.; Liu, C. J.
Article Title: Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss
Abstract: Glucocorticoids (GCs) are the most prescribed anti-inflammatory and immunosuppressive drugs. However, their use is often limited by substantial side effects, such as GC-induced osteoporosis (GIO) with the underlying mechanisms still not fully understood. In this study, we identify Tau as a low-affinity binding receptor for GCs that plays a crucial role in GIO. Tau deficiency largely abolished bone loss induced by high-dose dexamethasone, a synthetic GC, in both inflammatory arthritis and GIO models. Furthermore, TRx0237, a Tau inhibitor identified from an FDA-approved drug library, effectively prevented GIO. Notably, combinatorial administration of TRx0237 and dexamethasone completely overcame the osteoporosis adverse effect of dexamethasone in treating inflammatory arthritis. These findings present Tau as a previously unrecognized GC receptor with low affinity, and provide potential strategies to mitigate a spectrum of GC-related adverse effects, particularly osteoporosis. © The Author(s) 2024.
Keywords: controlled study; osteolysis; drug megadose; animal experiment; animal model; dexamethasone; food and drug administration; glucocorticoid; rheumatoid arthritis; osteoporosis; drug therapy; adverse drug reaction; therapy; human; male; article; hydromethylthionine
Journal Title: Cell Research
Volume: 35
Issue: 1
ISSN: 1001-0602
Publisher: Nature Publishing Group  
Date Published: 2025-01-01
Start Page: 23
End Page: 44
Language: English
DOI: 10.1038/s41422-024-01016-0
PUBMED: 39743632
PROVIDER: scopus
PMCID: PMC11701132
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Wenhuo Hu
    60 Hu